Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81
Document › Details

Autolus Therapeutics Ltd.. (1/5/17). "Press Release: Autolus to Present at J.P. Morgan Healthcare Conference". London.

Region Region San Francisco, CA
  Country United States (USA)
Organisations Organisation Autolus Therapeutics Ltd.
  Today Autolus Therapeutics plc (Nasdaq: AUTL)
  Group Autolus Therapeutics plc (Nasdaq: AUTL)
  Organisation 2 J.P. Morgan Securities LLC
  Group JPMorgan Chase (Group)
Products Product J.P. Morgan 35th Annual Healthcare Conference 2017 San Francisco
  Product 2 T cell therapy
Index term Index term Autolus–JPMorgan Chase: investor conference, 201701 supply service Autolus presents at JP Morgan Healthcare Conference 2017
Persons Person Itin, Christian (Autolus 201603– CEO before Cytos 201211–201601 + Micromet 1999–2012 CEO + Co-founder + Zyomyx Inc)
  Person 2 Wilson, Julia (JW Communications 201209– before Vectura Group)

Autolus Limited, a private biopharmaceutical company focused on the development and commercialisation of next-generation engineered T-cell therapies for haematological and solid tumours, announced today that Dr Christian Itin, Chief Executive Officer, is presenting at the 35th Annual J.P. Morgan Healthcare Conference on Monday 9 January 2017 at 7:30 a.m. PST at the Westin St. Francis Hotel, San Francisco, California.

– Ends –

Further information:

JW Communications
Julia Wilson
+44 (0)7818 430877

Notes for Editors:

About Autolus

Autolus is a private biopharmaceutical company, focused on the development and commercialisation of engineered T-cell immunotherapy products based on its proprietary T-cell programming technology. Autolus’ shareholders include Syncona LLP, UCL Business PLC, Woodford Investment Management LLP and Arix Bioscience plc. For further information please visit the Company’s website at:

Record changed: 2018-06-14


Picture ConsulTech GmbH RnD Credit Germany 650x80px

More documents for Autolus Therapeutics plc (Nasdaq: AUTL)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BioTech Showcase 2021 Digital Event BTS2021 651x81

» top